整形与烧伤领域色素性皮肤的診斷盲区:文献综述
结果显示红斑、变白、毛细血管再充盈在深色皮肤可靠性下降,15种瘢痕量表中仅3种在色素性皮肤验证;Fitzpatrick VI型皮瓣血管危象后丢失率85.7%,I型为21.4%。
要点
- 深色皮肤中红斑、变白和毛细血管再充盈等临床描述可靠性下降
- 15种常用瘢痕量表中仅3种在色素性皮肤中得到验证
- Fitzpatrick VI型皮瓣血管危象后丢失率85.7%,远高于I型的21.4%
核心结论
- 现有整形外科评估方法在深色皮肤患者中验证不足,导致诊断延迟和结局不公平。
- 亟需客观、涵盖不同肤色的诊断工具、按Fitzpatrick分型的验证及临床培训更新。
主要发现
- 临床描述如红斑、变白、毛细血管再充盈在深色皮肤所有受检临床情况中可靠性降低。
- 15种常用瘢痕量表中仅3种在色素性皮肤中验证;彩色摄影受黑色素相关动态范围衰减限制。
- 表皮下水份评估在浅表病理中证据最强,在深色皮肤有验证表现,并有荟萃分析显示减少2期压力性损伤。
- 深层成像(SFDI、HSI、NIRS、光声成像)易受黑色素相关信号失真,ICG血管造影和近红外激光多普勒相对稳健。
- Fitzpatrick VI型皮肤血管危象后皮瓣丢失率为85.7%,I型为21.4%;人工智能工具表现按肤色分层。
关键数值与推荐
- 15种常用瘢痕量表中仅3种在色素性皮肤中验证。
- Fitzpatrick VI型皮瓣血管危象后丢失率85.7%,I型为21.4%。
临床怎么用
- 深色皮肤患者中应谨慎解读红斑、变白和毛细血管再充盈等临床体征。
- 优先选用在深色皮肤有验证证据的评估工具,如ICG血管造影和近红外激光多普勒。
- 关注人工智能工具的肤色分层表现,推动肤色包容性诊断工具和培训。
局限性
- 本文为叙述性综述,未报告系统检索的样本量、偏倚评估等定量合并结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Plastic surgery relies heavily on the visual assessment of skin and soft tissues, yet most diagnostic descriptors, clinical scales, and imaging technologies have been developed and validated predominantly in lighter-skinned populations. This introduces systematic diagnostic uncertainty for patients with darker skin tones, with implications for burns, scars, pressure injury, superficial infection, and flap monitoring. This review synthesizes the current evidence on the performance of diagnostic modalities across the Fitzpatrick spectrum and identifies priority areas for research and training. METHODS: A narrative literature review was conducted across PubMed and Scopus from inception to October 2024. Controlled vocabulary and free-text terms covering skin tone, surgical conditions, and diagnostic techniques were combined with Boolean and adjacency operators. Studies were included if they explicitly addressed darker skin tones in the context of clinical assessment or monitoring. Evidence was appraised according to the Oxford Center for Evidence-Based Medicine Levels of Evidence. RESULTS: Findings are synthesized across 4 modality layers: clinical assessment, color photography, superficial imaging, and deep imaging with artificial intelligence. Clinical descriptors such as erythema, blanching, and capillary refill demonstrated reduced reliability in darker skin across all clinical conditions examined. Of the 15 commonly used scar scales, only 3 were validated in pigmented skin. Color photography was limited by melanin-related attenuation of dynamic range. Sub-epidermal moisture assessment had the strongest evidence base for superficial pathology, with validated performance in dark skin and meta-analytic reductions in stage 2 pressure injury. Deep imaging modalities (SFDI, HSI, NIRS, photoacoustic imaging) were susceptible to melanin-related signal distortion, whereas ICG angiography and near-infrared laser Doppler were relatively robust. Patients with Fitzpatrick type VI skin had a flap loss rate of 85.7% after vascular compromise, compared with 21.4% in type I. Artificial intelligence tools showed stratified performance by skin tone, underscoring the need for diverse training data sets. CONCLUSIONS: Current assessment methods in plastic surgery are insufficiently validated for patients with darker skin, contributing to diagnostic delay and inequitable outcomes. Objective, skin-tone-inclusive diagnostic tools, stratified validation across Fitzpatrick types, and updated clinical training are urgently needed to close this evidence gap.
引用
- Hagiga A, Davies L, Dheansa B, et al. Can You See It? Diagnostic Blind Spots in Pigmented Skin: A Review of the Literature in Plastic Surgery and Burns. Ann Plast Surg. 2026. PMID: 42748034. doi:10.1097/SAP.0000000000004878
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。